Cases 21 - 30 of 367
BioNTech SE et al v. CureVac SE
as 2:2023cv00222
Counter Defendant:
BIONTECH SE, BioNTech Manufacturing GmbH, Pfizer Inc. and others
Plaintiff:
Inc. Pfizer
Counter Claimant:
CureVac AG and Cure Vac AG
Defendant:
CureVac SE
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgment
GlaxoSmithKline Biologicals SA et al v. Pfizer Inc.
as 1:2023cv00831
Plaintiff:
GlaxoSmithKline Biologicals SA and GlaxoSmithKline LLC
Defendant:
Pfizer Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Pfizer Inc. et al v. Annora Pharma Private Limited et al
as 1:2023cv00634
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V. and others
Defendant:
Annora Pharma Private Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Promosome LLC v. Pfizer Inc. et al
as 3:2023cv01048
Plaintiff:
Promosome LLC
Defendant:
Pfizer Inc., BioNTech SE and BioNTech Manufacturing GmbH
Cause Of Action: 35 U.S.C. § 0271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al
as 1:2023cv00578
Plaintiff:
Alnylam Pharmaceuticals, Inc.
Defendant:
Pfizer Inc. and Pharmacia & Upjohn Co. LLC
Counter Claimant:
BioNTech SE and BioNTech Manufacturing GmbH
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Apotex Inc. et al
as 1:2023cv00445
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V. and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
as 3:2023cv01876
Plaintiff:
ARBUTUS PHARMA CORP. and GENEVANT SCIENCES GMBH
Defendant:
PFIZER INC. and BIONTECH SE
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
BioNTech SE et al v. CureVac AG
as 1:2022cv11202
Plaintiff:
BioNTech SE, BioNTech Manufacturing GmbH and Pfizer, Inc.
Defendant:
CureVac AG
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgment
Bristol-Myers Squibb Company et al v. Biocon Pharma Limited
as 1:2023cv00392
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Biocon Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Company et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv00393
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
